Bio­gen vet Adam Kop­pel is rais­ing cash for a new life sci­ences fund at Bain Cap­i­tal

Fol­low­ing a two-year stint as chief strat­e­gy of­fi­cer for Bio­gen, Adam Kop­pel took a new job last June helm­ing Bain Cap­i­tal’s in­vest­ments in biotech and life sci­ences. And now he’s gath­er­ing the cash for a new fund.

Kop­pel’s list­ed in the Form D filed with the SEC for Bain Cap­i­tal Life Sci­ences to­day, where he’s tak­en the role of man­ag­ing di­rec­tor. And while it doesn’t list an amount, Bain has a long his­to­ry of mak­ing a splash in what­ev­er field it’s work­ing in, with more than $75 bil­lion in man­aged cap­i­tal.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.